ES2070415T3 - Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b. - Google Patents

Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.

Info

Publication number
ES2070415T3
ES2070415T3 ES91202498T ES91202498T ES2070415T3 ES 2070415 T3 ES2070415 T3 ES 2070415T3 ES 91202498 T ES91202498 T ES 91202498T ES 91202498 T ES91202498 T ES 91202498T ES 2070415 T3 ES2070415 T3 ES 2070415T3
Authority
ES
Spain
Prior art keywords
directed against
antibodies directed
viruses
against hepatitis
reactive peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91202498T
Other languages
English (en)
Inventor
Winand Johannes Antoniu Habets
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of ES2070415T3 publication Critical patent/ES2070415T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

LA INVENCION SE REFIERE A PEPTIDOS QUE REACCIONAN INMUNOQUIMICAMENTE CON ANTICUERPOS DIRIGIDOS AL NANBH. ASI MISMO SE PRESENTA UN METODO PARA LA DETECCION DE NANBH O ANTI-NANBH EN UN FLUIDO DE PRUEBA, UN REAGENTE INMUNOQUIMICO Y UN EQUIPO DE PRUEBA PARA SER USADO CUANDO SE APLICAN LOS METODOS DE DETECCION QUE PERTENECEN A LA PRESENTE INVENCION.
ES91202498T 1990-10-05 1991-09-26 Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b. Expired - Lifetime ES2070415T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90202658 1990-10-05

Publications (1)

Publication Number Publication Date
ES2070415T3 true ES2070415T3 (es) 1995-06-01

Family

ID=8205138

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91202498T Expired - Lifetime ES2070415T3 (es) 1990-10-05 1991-09-26 Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.

Country Status (13)

Country Link
EP (1) EP0479376B1 (es)
JP (1) JPH05320192A (es)
KR (1) KR920008067A (es)
AT (1) ATE117696T1 (es)
AU (1) AU652581B2 (es)
CA (1) CA2052702A1 (es)
DE (1) DE69106998T2 (es)
DK (1) DK0479376T3 (es)
ES (1) ES2070415T3 (es)
FI (1) FI914673A (es)
GR (1) GR3015781T3 (es)
IE (1) IE65107B1 (es)
ZA (1) ZA917858B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0571554A1 (en) * 1991-01-14 1993-12-01 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
AU4946297A (en) * 1996-10-09 1998-05-05 Akzo Nobel N.V. A composition comprising an immobilised, acylated peptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus

Also Published As

Publication number Publication date
GR3015781T3 (en) 1995-07-31
EP0479376A1 (en) 1992-04-08
DE69106998T2 (de) 1995-05-24
CA2052702A1 (en) 1992-04-06
IE913390A1 (en) 1992-04-08
EP0479376B1 (en) 1995-01-25
DK0479376T3 (da) 1995-05-15
KR920008067A (ko) 1992-05-27
AU652581B2 (en) 1994-09-01
JPH05320192A (ja) 1993-12-03
FI914673A (fi) 1992-04-06
DE69106998D1 (de) 1995-03-09
ATE117696T1 (de) 1995-02-15
ZA917858B (en) 1992-07-29
FI914673A0 (fi) 1991-10-04
IE65107B1 (en) 1995-10-04
AU8562391A (en) 1992-04-09

Similar Documents

Publication Publication Date Title
ATE223044T1 (de) Nachweis von retikulozyten mit coriphosphin o
ATE185350T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
DE3750354D1 (de) Monoklonale Antikörper und Verfahren zum Nachweis von Dioxinen und Dibenzofuranen.
ATE410692T1 (de) Verfahren zur früherkennung der serokonversion eines gegen hepatitis c-virus gerichteten antikörpers
DE69432043T2 (de) Diagnostische Reagenzien zum Nachweis von Antikörper gegen EBV
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
ES2070415T3 (es) Peptidos inmunoquimicamente reactivos con anticuerpos dirigidos contra el virus de la hepatitis no-a, no-b.
DK0552829T3 (da) CENP-B-peptid
ES2066547T3 (es) Peptidos, inmunoquimicamente reactivos con anticuerpos dirigidos contra virus de hepatitis no-a, no-b.
ES2069298T3 (es) Secuencias no-a no-b.
DE69128238D1 (de) Nachweis von thrombopenies
WO1993011158A3 (en) Non-a, non-b peptides
DE59301478D1 (de) Nachweis von viralen oder bakteriellen Antigenen mittels Durchflusscytometrie
KR930007970A (ko) 비-에이 형 , 비-비형 펩티드
EP0362910A3 (en) Synthetic peptides immunochemically reactive with hiv-antibodies
FI952778A0 (fi) Hepatiitti-C-viruksen (HCV) 3-ei-rakenne-peptidejä, vasta-aineita niitä vastaan ja menetelmiä HCV:n toteamiseksi
KR930700551A (ko) 비-a형, 비-b형 염기서열

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 479376

Country of ref document: ES